TY - BOOK ID - 32842195 TI - Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions AU - Pai, Manjunath P. AU - Kiser, Jennifer J. AU - Gubbins, Paul O. AU - Rodvold, Keith A. PY - 2018 SN - 3319724169 3319724150 PB - Cham : Springer International Publishing : Imprint: Humana, DB - UniCat KW - Drug interactions. KW - Anti-infective agents. KW - Communicable diseases. KW - Medicine. KW - Pharmacy. KW - Pharmaceutical technology. KW - Infectious diseases. KW - Biomedicine. KW - Pharmaceutical Sciences/Technology. KW - Infectious Diseases. KW - Pharmaceutical laboratory techniques KW - Pharmaceutical laboratory technology KW - Technology, Pharmaceutical KW - Technology KW - Chemistry KW - Medicine KW - Drugs KW - Materia medica KW - Pharmacology KW - Clinical sciences KW - Medical profession KW - Human biology KW - Life sciences KW - Medical sciences KW - Pathology KW - Physicians KW - Contagion and contagious diseases KW - Contagious diseases KW - Infectious diseases KW - Microbial diseases in human beings KW - Zymotic diseases KW - Diseases KW - Infection KW - Epidemics KW - Antiinfective agents KW - Antimicrobial agents KW - Antimicrobial drugs KW - Antimicrobials KW - Interactions, Drug KW - Side effects KW - Emerging infectious diseases. KW - Emerging infections KW - New infectious diseases KW - Re-emerging infectious diseases KW - Reemerging infectious diseases KW - Communicable diseases UR - https://www.unicat.be/uniCat?func=search&query=sysid:32842195 AB - The 4th edition of Drug Interactions in Infectious Diseases is being split into two separate volumes – “Mechanisms and Models of Drug Interactions” and “Antimicrobial Drug Interactions”. This volume, “Antimicrobial Drug Interactions,” delivers a quick clinical resource that distills relevant drug interactions by antimicrobial drug class. The book provides informative tables on specific drug-drug interactions that include the degree and severity of the expected interaction. A mechanistic basis for drug-drug interactions is also provided to link observed interactions to pharmacologic characteristics of key drug classes. This complete resource is organized by major antibacterial, antimycobacterial, antiviral, antifungal, antimalarial, and antiprotozoal class. In line with current innovations in antimicrobial drug development, a distinct chapter on the pharmacologic management of drug interactions in hepatitis B virus (HBV) and hepatitis C virus (HCV)-related infections is included. Two new chapters are dedicated to the management of human immunodeficiency virus (HIV) drug-drug interactions given the breadth of antiretroviral class-specific effects. This comprehensive review of known drug interactions and strategies to manage them is an invaluable resource to all health care practitioners. ER -